PRLD: Prelude Therapeutics Incorporated Stock

by  •  • Comments Off on PRLD: Prelude Therapeutics Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 235.10
Enterprise Value ($M) 210.39
Book Value ($M) 210.73
Book Value / Share 3.84
Price / Book 1.12
NCAV ($M) 168.99
NCAV / Share 3.08
Price / NCAV 1.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.55
Return on Assets (ROA) -0.63
Return on Equity (ROE) -0.72

Liquidity (mrq)
Quick Ratio 11.64
Current Ratio 11.64

Balance Sheet (mrq) ($M)
Current Assets 205.37
Assets 247.11
Liabilities 36.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -132.28
Net Income -121.83

Cash Flow Statement (mra) ($M)
Cash From Operations -107.06
Cash from Investing -34.65
Cash from Financing 136.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Ubs Asset Management Americas Inc 0.00 -100.00
02-12 13G/A Vaddi Krishna 11.10 14.16
02-12 13G/A Flynn James E 9.85 28.25
01-10 13G/A Fmr Llc 0.63 -94.57
12-13 13D/A Baker Bros. Advisors Lp 24.30 0.04
05-24 13D/A Orbimed Advisors Llc 28.60 5.86

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 12,008 18,982 63.26
2024-05-16 6,969 21,951 31.75
2024-05-15 3,419 48,888 6.99
2024-05-14 2,663 27,741 9.60

(click for more detail)

Similar Companies
PLRX – Pliant Therapeutics, Inc. PMVP – PMV Pharmaceuticals, Inc.
PRAX – Praxis Precision Medicines, Inc. PRTA – Prothena Corporation plc
PTCT – PTC Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io